Chris Peritore-Galve, PhD

Thrilled to share our new study from the @BordenLacy Lab in collaboration with @AstraZenecaUS, "The monoclonal antibody AZD5148 confers broad protection against TcdB-diverse Clostridioides difficile strains in mice” now out in PLoS Pathogens! doi.org/10.1371/journa…

The Peritore Lab officially opens its doors in 2026! I am seeking an organized, motivated technician to join our team focused on host-pathogen interaction research. For details on current research, check out: peritorelab.com Job listing: osu.wd1.myworkdayjobs.com/OSUCareers/job…

20/20 This was a fun and important study, and it was a pleasure to collaborate between the @BordenLacy Lab and our brilliant colleagues at @AstraZenecaUS ! @RubenCanoRdz @SLKordus @ReeceKnippel & everyone else I couldn't find/tag

19/20 AZD5148 is currently in Phase I clinical trials (NCT06469151), and we are hopeful that this monoclonal antibody will help C. difficile patients in the future.

Thrilled to share our new study from the @BordenLacy Lab in collaboration with @AstraZenecaUS, "The monoclonal antibody AZD5148 confers broad protection against TcdB-diverse Clostridioides difficile strains in mice” now out in PLoS Pathogens! doi.org/10.1371/journa…